Congruence secures a $5 million grant to advance innovative therapies for GBA1 Parkinson's disease, enhancing hope for ...

A deep dive into the implications of the Replimune CRL that surprised insiders and investors, the role of new leadership at ...

A global survey of scientists and informaticians reveals growing AI investment across the biopharma value chain, but ...

The acquisition led by Advent International will see the two AI-powered companies combine forces to improve the healthcare ...

The side effects that come with many cancer treatments can cause people to delay or avoid treatment.

Unlock the secrets of executive presence in pharma to inspire confidence, influence decisions, and elevate your leadership ...

Global leader in mother and childcare, Philips Avent, announced a partnership with March of Dimes to establish the modern-day ...

Copycats and false advertisements are also to blame for the increased threats. Stemming from social media testimonials all ...

The EVERSANA AI Accelerator is our dedicated center of excellence designed to harness the power of artificial intelligence ...

With reports that FDA’s AI Elsa is “confidently hallucinating” studies that don’t exist, the use of AI to streamline drug ...

Neha Anand, Analyst, Biopharma Intelligence Services, Citeline, highlights Emrelis’ potential to broaden its clinical impact ...

A special live broadcast of award-winning star and CEO’s conversation will focus on advancements and regulations on ALS ...